Abstract: A method for generating a treatment plan in response to medical test results is provided. The method comprises receiving at a server one or more test results as a result of operation of a medical testing device, wherein the one or more test results includes a determination of the efficacy and dosage level of a medication, generating at the server an updated digital patient record reflecting the one or more test results, and transmitting by the server to a medical entity a treatment plan based on the efficacy and dosage level determined for the medication, wherein the treatment plan is a dosage regimen for the medication.
Type:
Grant
Filed:
November 10, 2018
Date of Patent:
February 23, 2021
Assignee:
RELIANT IMMUNE DIAGNOSTICS, INC.
Inventors:
Jovan Hutton Pulitzer, Henry Joseph Legere, III
Abstract: A method for generating a treatment plan in response to medical test results is provided. The method comprises requesting point-of-care (POC) services from a mobile POC unit, receiving at a server confirmation of delivery of POC services to a patient, receiving at the server one or more test results as a result of operation of a medical testing device used in the POC services, wherein the one or more test results includes a determination of the efficacy and dosage level of a medication, generating at the server an updated digital patient record reflecting the one or more test results, and transmitting by the server to a medical entity a treatment plan based on the efficacy and dosage level determined for the medication, wherein the treatment plan is a dosage regimen for the medication.
Type:
Grant
Filed:
November 14, 2018
Date of Patent:
February 23, 2021
Assignee:
RELIANT IMMUNE DIAGNOSTICS, INC.
Inventors:
Jovan Hutton Pulitzer, Henry Joseph Legere, III
Abstract: A microfluidic chip system includes an input for receiving the biologic sample, and a first reading window for enabling a detection of the biologic material within the biologic sample. A first plurality of pathways is provided each for determining a treatment agent providing a best treatment efficacy for the predetermined biologic material. A first micro-pump is provided for pumping a portion of the biologic sample into each of the first plurality of pathways. A second plurality of pathways is provided, each for determining a dosage level of a particular one of the plurality of treatment agents with respect to the predetermined biologic material. A plurality of second micro-pumps are provided for pumping a second portion of the biologic sample into a selected one of the second plurality of pathways responsive to the determination of treatment efficacy of the treatment agent providing a best treatment of the predetermined biologic material.
Type:
Grant
Filed:
November 10, 2018
Date of Patent:
September 21, 2021
Assignee:
RELIANT IMMUNE DIAGNOSTICS, INC.
Inventors:
Jovan Hutton Pulitzer, Henry Joseph Legere, III